Ticker LaunchSPAC · Liquidated
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. is a blank-check company (SPAC) that raised $200M in its initial public offering on Dec 6, 2021, listing on Nasdaq Global Market. It did not complete a business combination and liquidated around Oct 4, 2023, returning the trust to public shareholders. Jasper Capital Partners led the IPO, with CoreTek. Latham & Watkins advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Dec 6, 2021
- IPO size
- $200M
- IPO exchange
- Nasdaq Global Market
- IPO underwriters
- Jasper Capital Partners and CoreTek
- SPAC counsel (IPO)
- Latham & Watkins and Walkers
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Dec 6, 2021
- All filings on EDGAR CIK 1856653
Other SPAC IPOs from 2021
- APx Acquisition Corp. IDec 8, 2021 · $150M
- Globalink Investment Inc.Dec 8, 2021 · $100M
- Crypto 1 Acquisition CorpDec 8, 2021 · $200M
- Motive Capital Corp IIDec 8, 2021 · $300M
- Jupiter Wellness Acquisition Corp.Dec 8, 2021 · $120M
- Blue Ocean Acquisition CorpDec 6, 2021 · $165M